Please assess the completion status of the following clinical trial:

Trial Title: Donor Dopamine and Initial Graft Function

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Donors:~* Brain death confirmed~* Given consent to organ donation~* Current s-creatinine \< 2mg/dl~* On admission s-creatinine \< 1.3mg/dl~Recipients:~* Age over 18 years~* Placed on the waiting list~* Organ allocation according to ET standards~Exclusion Criteria:~Donors:~* Application of dopamine/dobutamine/adrenaline~* Application of noradrenaline \> 0.4µg/kg\*min~* Hemodynamic instability~Recipients:~* Refusal to participate in study /data analysis~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).